Sign in

CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851763759
Phone
919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 424B3 Offering Prospectus
  14. 8-K Event Shareholder vote results
  15. 4 Open-market buy Chief Commercial Officer bought 10,525 shares at $4.72 ($49,678)
  16. 4 Open-market buy Director bought 10,000 shares at $4.83 ($48,300)
  17. 4 Open-market buy President, CEO and Director bought 10,000 shares at $4.83 ($48,300)
  18. 4 Open-market buy Director bought 2,000 shares at $4.83 ($9,660)
  19. 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 2,000 shares at $4.53 ($9,060)
  20. 424B3 Offering Prospectus

Page 18 of 26 · 506 filings